BRIVIACT (brivaracetam) Patient Assistance Program
Don’t let the high cost of brand specialty epilepsy therapy disrupt your treatment. We help eligible patients access Briviact (brivaracetam) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Briviact (brivaracetam) is FDA-approved for partial-onset seizures in patients ≥1 month. It is a structurally related successor to levetiracetam (Keppra) with higher selectivity for SV2A (synaptic vesicle protein 2A).
- Without assistance, brand Briviact costs commonly run approximately $700–$900 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Briviact for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic brivaracetam is now available at lower cost. Generic levetiracetam (Keppra equivalent) is widely available at very low cost — often $4–$15/month — and is the most affordable SV2A antiepileptic for most patients.
What Is Briviact Prescription Assistance Program?
The Briviact Prescription Assistance Program is a manufacturer-sponsored initiative for partial-onset seizure patients who are uninsured or underinsured.
Navigating on your own means dealing with eligibility verification, neurology coordination, prior-authorization, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment.
Pharmacy Price Comparison
- Without assistance, brand Briviact costs roughly $700–$900/month. Generic alternatives are dramatically cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$880 | Save ~$810/mo |
| CVS Pharmacy (brand) | ~$900 | Save ~$830/mo |
| Walmart (brand) | ~$740 | Save ~$670/mo |
| Costco (brand) | ~$720 | Save ~$650/mo |
Generic levetiracetam | ~$10 | Already — low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Briviact Prescription Program?
The Patient Assistance Program is free to apply for and provides Briviact at no medication cost if approved. Our $69.95/month service covers full advocacy. Generic levetiracetam is the most affordable SV2A antiepileptic for most patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Briviact:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $700–$900 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Briviact assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Briviact Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Briviact:
Briviact (brivaracetam) is a twice-daily oral antiepileptic — a more selective successor to levetiracetam (Keppra) targeting synaptic vesicle protein 2A (SV2A). It is used for partial-onset seizures, often as add-on therapy in patients inadequately controlled on other AEDs.
How Briviact Works:
Partial-onset seizures arise from a focal area of the brain. SV2A is a synaptic vesicle protein involved in neurotransmitter release. Modulating SV2A reduces excessive neurotransmitter release contributing to seizures.
Brivaracetam binds SV2A with ~20x higher affinity than levetiracetam. The clinical advantage over levetiracetam may include faster onset and potentially better tolerability regarding behavioral side effects (irritability, depression) that affect some patients on Keppra — but evidence for clear superiority is modest. Generic levetiracetam works well for most patients at a fraction of the cost.
Form and use:
Briviact is taken by mouth twice daily, with or without food. Tablets, oral solution, and IV form available. Starting dose 50 mg BID; max 100 mg BID. Renal/hepatic dose adjustment may be needed.
Generic availability:
Generic brivaracetam is now available. Generic levetiracetam (Keppra IR and XR) is widely available at very low cost. Other AEDs for partial-onset seizures: lamotrigine, oxcarbazepine, lacosamide (Vimpat, generic), perampanel (Fycompa), carbamazepine, valproate, and many others.
Warnings:
Briviact carries warnings for suicidal ideation (class effect of AEDs), neuropsychiatric reactions (irritability, agitation, depression — potentially less than levetiracetam), CNS depression (somnolence, dizziness, fatigue), and hypersensitivity reactions. Avoid abrupt discontinuation.
FAQ (Frequently Asked Questions)
How Much Does Briviact Cost Without Insurance?
Brand Briviact costs ~$700–$900/month. Generic levetiracetam is dramatically cheaper (~$4–$15/month). Through AffordMyPrescriptions, qualifying patients receive Briviact at no medication cost — our $69.95 monthly fee covers full advocacy
Should I Try Generic Levetiracetam First?
Often yes. Generic levetiracetam is dramatically cheaper and effective for most patients with partial-onset seizures. Most insurance plans require trial of generic levetiracetam before approving Briviact. Briviact may be preferable for patients who experience irritability or behavioral issues on levetiracetam.
How Is Briviact Different From Keppra?
Both target SV2A but brivaracetam binds with ~20x higher affinity. May have faster onset of action and possibly fewer behavioral side effects than levetiracetam. The clinical difference is modest for most patients. Levetiracetam has many years of widespread use and is much cheaper as a generic
What About Behavioral Side Effects?
Levetiracetam is associated with irritability, mood changes, and behavioral disturbances in some patients (especially children and adolescents). Some patients tolerate Briviact better in this regard. Tell your neurologist about mood or behavioral changes.
Can I Switch From Keppra Directly?
Yes — brivaracetam can be substituted for levetiracetam at conversion doses (typically 200 mg brivaracetam = 3000 mg levetiracetam). No taper required when switching between these two SV2A-binding AEDs.
Are There Drug Interactions
Few. Brivaracetam is metabolized primarily by hydrolysis (not CYP); strong CYP3A inducers (carbamazepine, phenytoin, phenobarbital, rifampin) reduce brivaracetam levels modestly. Generally fewer interactions than older AEDs
What If My Application Is Denied?
We explore alternatives — generic levetiracetam (much cheaper, often very effective), generic brivaracetam, other AEDs, manufacturer copay program, or independent foundations like the Epilepsy Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Briviact, our team may be able to help you access assistance programs — or guide you to generic levetiracetam or generic brivaracetam. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.